Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,75 USD | +1,28% | +4,63% | -26,81% |
10/04 | Terns Pharmaceuticals, Inc. benoemt Melita Sun Jung tot Chief Business Officer | CI |
27/03 | TERNS PHARMACEUTICALS, INC. : UBS herhaalt koopadvies | ZM |
Omzet 2024 * | 1,67 mln. 1,56 mln. | Omzet 2025 * | 2,17 mln. 2,03 mln. | Marktkapitalisatie | 307 mln. 287 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -108 mln. -101 mln. | Nettowinst (verlies) 2025 * | -127 mln. -119 mln. | EV/omzet 2024 * | 61,3 x |
Nettoliquiditeiten 2024 * | 205 mln. 191 mln. | Nettoliquiditeiten 2025 * | 186 mln. 174 mln. | EV/omzet 2025 * | 55,6 x |
K/w-verhouding 2024 * |
-3,41
x | K/w-verhouding 2025 * |
-3,37
x | Werknemers | 66 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,48% |
1 dag | +1,28% | ||
1 week | +4,63% | ||
Lopende maand | -27,59% | ||
1 maand | -28,03% | ||
3 maanden | -12,04% | ||
6 maanden | -12,36% | ||
Lopend jaar | -26,81% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Amy Burroughs
CEO | Chief Executive Officer | 53 | 07/02 |
Erin Quirk
PSD | President | 53 | 01-01-19 |
Mark Vignola
DFI | Director of Finance/CFO | 46 | 11-08-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Fellows
CHM | Chairman | 67 | 01-12-20 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 01-12-20 |
Carl Gordon
BRD | Director/Board Member | 59 | 01-10-18 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - | |
0.00% | 34 M€ | +2,35% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 4,75 | +1,28% | 557 257 |
23-04-24 | 4,69 | -2,70% | 544 113 |
22-04-24 | 4,82 | +5,70% | 535 597 |
19-04-24 | 4,56 | -0,65% | 866 472 |
18-04-24 | 4,59 | +1,10% | 694 069 |
uitgestelde koers Nasdaq, 24 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-26,81% | 303 mln. | |
+4,09% | 43,43 mld. | |
+47,81% | 41,69 mld. | |
+9,45% | 41,31 mld. | |
-10,92% | 27,14 mld. | |
+9,32% | 25,28 mld. | |
-24,87% | 18,47 mld. | |
+29,70% | 12,59 mld. | |
+1,28% | 12,33 mld. | |
+7,78% | 11,03 mld. |